Dr. Randal S. Weber on Anti-EGFR Agents Showing Efficacy in Squamous Cell Carcinoma
Weber says overactivity of these EGFR receptors may cause SCC tumors to become more aggressive. He adds that in a recent, small-scale study, effectively blocking the EGFR receptor in the tumor with anti-EGFR therapy proved to be successful.
Randal S. Weber, MD, FACS, head of the Department of Head and Neck Surgery, MD Anderson Cancer Center, discusses the importance of the epidermal growth factor receptor (EGFR) in squamous cell carcinoma (SCC). Weber says overactivity of these EGFR receptors may cause SCC tumors to become more aggressive. He adds that in a recent, small-scale study, effectively blocking the EGFR receptor in the tumor with anti-EGFR therapy proved to be successful.
Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond
March 21st 2025Frank J. Penedo, PhD, explains the challenges of survivorship care for patients with cancer and how he implements programs to support patients’ emotional, physical, and practical needs.
Read More
